• Profile
Close

Exploratory analysis of serum concentrations of oocyte biomarkers growth differentiation factor 9 and bone morphogenetic protein 15 in ovulatory women across the menstrual cycle

Fertility and Sterility Apr 02, 2021

Riepsamen AH, Donoghoe MW, Baerwald A, et al. - Researchers conducted a cross-sectional, observational, and exploratory study in order to describe and evaluate the changes in serum concentrations of oocyte-secreted growth differentiation factor 9 (GDF9) and bone morphogenetic protein 15 (BMP15) throughout the menstrual cycle in women from young to advanced reproductive ages. From 3 cohorts of healthy, ovulatory women, serum was obtained every 1–3 days throughout the menstrual cycle for this analysis: menses to late luteal phase (21–29 years of age; n = 16; University of Otago) and across one interovulatory interval (18-35 years of age; n = 10; and 45–50 years of age; n = 15; University of Saskatchewan). Fifty-four percent and 73% of women had detectable GDF9 and BMP15, respectively, and their concentrations varied 236-fold and 52-fold between women, respectively. Findings revealed no statistically detectable serial changes in GDF9 or BMP15 concentrations across the cycle and these are likewise similar across the reproductive lifespan.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay